“Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease”, ccm, vol. 10, no. 2, pp. 71–78, Apr. 2026, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/16687